Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states.
Identifieur interne : 000846 ( PubMed/Corpus ); précédent : 000845; suivant : 000847Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states.
Auteurs : John Kinsman ; John Angrén ; Fredrik Elgh ; Maria Furberg ; Paola A. Mosquera ; Laura Otero-García ; René Snacken ; Tarik Derrough ; Paloma Carrillo Santisteve ; Massimo Ciotti ; Svetla TsolovaSource :
- BMC health services research [ 1472-6963 ] ; 2018.
English descriptors
- KwdEn :
- Communicable Disease Control (methods), Communicable Disease Control (organization & administration), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Disease Outbreaks (prevention & control), Europe (epidemiology), European Union, Focus Groups, Health Planning (organization & administration), Humans, Interviews as Topic, Poliomyelitis (epidemiology), Poliomyelitis (prevention & control), Qualitative Research.
- MESH :
- epidemiology : Coronavirus Infections, Europe, Poliomyelitis.
- methods : Communicable Disease Control.
- organization & administration : Communicable Disease Control, Health Planning.
- prevention & control : Coronavirus Infections, Disease Outbreaks, Poliomyelitis.
- European Union, Focus Groups, Humans, Interviews as Topic, Qualitative Research.
Abstract
EU Decision 1082/2013/EU on serious cross-border health threats provides a legal basis for collaboration between EU Member States, and between international and European level institutions on preparedness, prevention, and mitigation in the event of a public health emergency. The Decision provides a context for the present study, which aims to identify good practices and lessons learned in preparedness and response to Middle East Respiratory Syndrome (MERS) (in UK, Greece, and Spain) and poliomyelitis (in Poland and Cyprus).
DOI: 10.1186/s12913-018-3326-0
PubMed: 29976185
Links to Exploration step
pubmed:29976185Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states.</title><author><name sortKey="Kinsman, John" sort="Kinsman, John" uniqKey="Kinsman J" first="John" last="Kinsman">John Kinsman</name><affiliation><nlm:affiliation>Department of Public Health and Clinical Medicine, Epidemiology and Global Health Unit, Umeå University, 901 87, Umeå, Sweden. john.kinsman@umu.se.</nlm:affiliation></affiliation></author><author><name sortKey="Angren, John" sort="Angren, John" uniqKey="Angren J" first="John" last="Angrén">John Angrén</name><affiliation><nlm:affiliation>European CBRNE Centre, Umeå University, 901 85, Umeå, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Elgh, Fredrik" sort="Elgh, Fredrik" uniqKey="Elgh F" first="Fredrik" last="Elgh">Fredrik Elgh</name><affiliation><nlm:affiliation>Department of Clinical Microbiology, Umeå University, 901 85, Umeå, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Furberg, Maria" sort="Furberg, Maria" uniqKey="Furberg M" first="Maria" last="Furberg">Maria Furberg</name><affiliation><nlm:affiliation>Department of Clinical Microbiology, Umeå University, 901 85, Umeå, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Mosquera, Paola A" sort="Mosquera, Paola A" uniqKey="Mosquera P" first="Paola A" last="Mosquera">Paola A. Mosquera</name><affiliation><nlm:affiliation>Department of Public Health and Clinical Medicine, Epidemiology and Global Health Unit, Umeå University, 901 87, Umeå, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Otero Garcia, Laura" sort="Otero Garcia, Laura" uniqKey="Otero Garcia L" first="Laura" last="Otero-García">Laura Otero-García</name><affiliation><nlm:affiliation>Nursing Section, Faculty of Medicine, Autonoma de Madrid University, Madrid, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Snacken, Rene" sort="Snacken, Rene" uniqKey="Snacken R" first="René" last="Snacken">René Snacken</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Derrough, Tarik" sort="Derrough, Tarik" uniqKey="Derrough T" first="Tarik" last="Derrough">Tarik Derrough</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Carrillo Santisteve, Paloma" sort="Carrillo Santisteve, Paloma" uniqKey="Carrillo Santisteve P" first="Paloma" last="Carrillo Santisteve">Paloma Carrillo Santisteve</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Ciotti, Massimo" sort="Ciotti, Massimo" uniqKey="Ciotti M" first="Massimo" last="Ciotti">Massimo Ciotti</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Tsolova, Svetla" sort="Tsolova, Svetla" uniqKey="Tsolova S" first="Svetla" last="Tsolova">Svetla Tsolova</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29976185</idno><idno type="pmid">29976185</idno><idno type="doi">10.1186/s12913-018-3326-0</idno><idno type="wicri:Area/PubMed/Corpus">000846</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000846</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states.</title><author><name sortKey="Kinsman, John" sort="Kinsman, John" uniqKey="Kinsman J" first="John" last="Kinsman">John Kinsman</name><affiliation><nlm:affiliation>Department of Public Health and Clinical Medicine, Epidemiology and Global Health Unit, Umeå University, 901 87, Umeå, Sweden. john.kinsman@umu.se.</nlm:affiliation></affiliation></author><author><name sortKey="Angren, John" sort="Angren, John" uniqKey="Angren J" first="John" last="Angrén">John Angrén</name><affiliation><nlm:affiliation>European CBRNE Centre, Umeå University, 901 85, Umeå, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Elgh, Fredrik" sort="Elgh, Fredrik" uniqKey="Elgh F" first="Fredrik" last="Elgh">Fredrik Elgh</name><affiliation><nlm:affiliation>Department of Clinical Microbiology, Umeå University, 901 85, Umeå, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Furberg, Maria" sort="Furberg, Maria" uniqKey="Furberg M" first="Maria" last="Furberg">Maria Furberg</name><affiliation><nlm:affiliation>Department of Clinical Microbiology, Umeå University, 901 85, Umeå, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Mosquera, Paola A" sort="Mosquera, Paola A" uniqKey="Mosquera P" first="Paola A" last="Mosquera">Paola A. Mosquera</name><affiliation><nlm:affiliation>Department of Public Health and Clinical Medicine, Epidemiology and Global Health Unit, Umeå University, 901 87, Umeå, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Otero Garcia, Laura" sort="Otero Garcia, Laura" uniqKey="Otero Garcia L" first="Laura" last="Otero-García">Laura Otero-García</name><affiliation><nlm:affiliation>Nursing Section, Faculty of Medicine, Autonoma de Madrid University, Madrid, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Snacken, Rene" sort="Snacken, Rene" uniqKey="Snacken R" first="René" last="Snacken">René Snacken</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Derrough, Tarik" sort="Derrough, Tarik" uniqKey="Derrough T" first="Tarik" last="Derrough">Tarik Derrough</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Carrillo Santisteve, Paloma" sort="Carrillo Santisteve, Paloma" uniqKey="Carrillo Santisteve P" first="Paloma" last="Carrillo Santisteve">Paloma Carrillo Santisteve</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Ciotti, Massimo" sort="Ciotti, Massimo" uniqKey="Ciotti M" first="Massimo" last="Ciotti">Massimo Ciotti</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author><author><name sortKey="Tsolova, Svetla" sort="Tsolova, Svetla" uniqKey="Tsolova S" first="Svetla" last="Tsolova">Svetla Tsolova</name><affiliation><nlm:affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</nlm:affiliation></affiliation></author></analytic><series><title level="j">BMC health services research</title><idno type="eISSN">1472-6963</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Disease Control (methods)</term><term>Communicable Disease Control (organization & administration)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (prevention & control)</term><term>Disease Outbreaks (prevention & control)</term><term>Europe (epidemiology)</term><term>European Union</term><term>Focus Groups</term><term>Health Planning (organization & administration)</term><term>Humans</term><term>Interviews as Topic</term><term>Poliomyelitis (epidemiology)</term><term>Poliomyelitis (prevention & control)</term><term>Qualitative Research</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Europe</term><term>Poliomyelitis</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term><term>Health Planning</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Disease Outbreaks</term><term>Poliomyelitis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>European Union</term><term>Focus Groups</term><term>Humans</term><term>Interviews as Topic</term><term>Qualitative Research</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">EU Decision 1082/2013/EU on serious cross-border health threats provides a legal basis for collaboration between EU Member States, and between international and European level institutions on preparedness, prevention, and mitigation in the event of a public health emergency. The Decision provides a context for the present study, which aims to identify good practices and lessons learned in preparedness and response to Middle East Respiratory Syndrome (MERS) (in UK, Greece, and Spain) and poliomyelitis (in Poland and Cyprus).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29976185</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>07</Month><Day>06</Day></PubDate></JournalIssue><Title>BMC health services research</Title><ISOAbbreviation>BMC Health Serv Res</ISOAbbreviation></Journal><ArticleTitle>Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states.</ArticleTitle><Pagination><MedlinePgn>528</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12913-018-3326-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">EU Decision 1082/2013/EU on serious cross-border health threats provides a legal basis for collaboration between EU Member States, and between international and European level institutions on preparedness, prevention, and mitigation in the event of a public health emergency. The Decision provides a context for the present study, which aims to identify good practices and lessons learned in preparedness and response to Middle East Respiratory Syndrome (MERS) (in UK, Greece, and Spain) and poliomyelitis (in Poland and Cyprus).</AbstractText><AbstractText Label="METHODS">Based on a documentary review, followed by five week-long country visits involving a total of 61 interviews and group discussions with experts from both the health and non-health sectors, this qualitative case study has investigated six issues related to preparedness and response to MERS and poliomyelitis: national plans and overall preparedness capacity; training and exercises; risk communication; linking policy and implementation; interoperability between the health and non-health sectors; and cross-border collaboration.</AbstractText><AbstractText Label="RESULTS">Preparedness and response plans for MERS and poliomyelitis were in place in the participating countries, with a high level of technical expertise available to implement them. Nevertheless, formal evaluation of the responses to previous public health emergencies have sometimes been limited, so lessons learned may not be reflected in updated plans, thereby risking mistakes being repeated in future. The nature and extent of inter-sectoral collaboration varied according to the sectors involved, with those sectors that have traditionally had good collaboration (e.g. animal health and food safety), as well as those that have a financial incentive for controlling infectious diseases (e.g. agriculture, tourism, and air travel) seen as most likely to have integrated public health preparedness and response plans. Although the formal protocols for inter-sectoral collaboration were not always up to date, good personal relations were reported within the relevant professional networks, which could be brought into play in the event of a public health emergency. Cross-border collaboration was greatly facilitated if the neighbouring country was a fellow EU Member State.</AbstractText><AbstractText Label="CONCLUSIONS">Infectious disease outbreaks remain as an ongoing threat. Efforts are required to ensure that core public health capacities for the full range of preparedness and response activities are sustained.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinsman</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1332-4138</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Clinical Medicine, Epidemiology and Global Health Unit, Umeå University, 901 87, Umeå, Sweden. john.kinsman@umu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angrén</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>European CBRNE Centre, Umeå University, 901 85, Umeå, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elgh</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Umeå University, 901 85, Umeå, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furberg</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Umeå University, 901 85, Umeå, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosquera</LastName><ForeName>Paola A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Public Health and Clinical Medicine, Epidemiology and Global Health Unit, Umeå University, 901 87, Umeå, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otero-García</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nursing Section, Faculty of Medicine, Autonoma de Madrid University, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snacken</LastName><ForeName>René</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derrough</LastName><ForeName>Tarik</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrillo Santisteve</LastName><ForeName>Paloma</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciotti</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsolova</LastName><ForeName>Svetla</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>European Centre for Disease Prevention and Control, Granits väg 8, 171 65, Solna, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Framework Contract ECDC/2014/005</GrantID><Agency>European Centre for Disease Prevention and Control</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Health Serv Res</MedlineTA><NlmUniqueID>101088677</NlmUniqueID><ISSNLinking>1472-6963</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005062" MajorTopicYN="N">European Union</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006285" MajorTopicYN="N">Health Planning</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Cross-border</Keyword><Keyword MajorTopicYN="Y">European Union</Keyword><Keyword MajorTopicYN="Y">Inter-sectoral</Keyword><Keyword MajorTopicYN="Y">Interoperability</Keyword><Keyword MajorTopicYN="Y">MERS-coronavirus</Keyword><Keyword MajorTopicYN="Y">Poliomyelitis</Keyword><Keyword MajorTopicYN="Y">Preparedness and response</Keyword><Keyword MajorTopicYN="Y">Public health</Keyword><Keyword MajorTopicYN="Y">Risk communication</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>06</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29976185</ArticleId><ArticleId IdType="doi">10.1186/s12913-018-3326-0</ArticleId><ArticleId IdType="pii">10.1186/s12913-018-3326-0</ArticleId><ArticleId IdType="pmc">PMC6034236</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMJ. 2013 Jun 13;346:f2363</Citation><ArticleIdList><ArticleId IdType="pubmed">23766463</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Public Health. 2007;28:1-18</Citation><ArticleIdList><ArticleId IdType="pubmed">17129174</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Health Serv. 2016;46(2):283-99</Citation><ArticleIdList><ArticleId IdType="pubmed">26825100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2013 Apr 13;381(9874):1323-31</Citation><ArticleIdList><ArticleId IdType="pubmed">23541059</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Public Health. 2016 May-Jun;9(3):208-12</Citation><ArticleIdList><ArticleId IdType="pubmed">27158023</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2015 Feb 1;60(3):378-80</Citation><ArticleIdList><ArticleId IdType="pubmed">25323703</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2014 Jan;59(1):4-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24286807</ArticleId></ArticleIdList></Reference><Reference><Citation>Disaster Med Public Health Prep. 2008 Dec;2(4):251-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18824920</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-341-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15451958</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosecur Bioterror. 2013 Dec;11(4):251-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24251597</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2016 Apr;45:1-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26875601</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Res Notes. 2014 Jul 27;7:474</Citation><ArticleIdList><ArticleId IdType="pubmed">25063987</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1999 Oct 29;17 Suppl 3:S41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10559533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Sep 3;388(10048):942-3</Citation><ArticleIdList><ArticleId IdType="pubmed">27402382</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2014 Jun 4;311(21):2160-1</Citation><ArticleIdList><ArticleId IdType="pubmed">24893074</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2017 Feb;23(2):232-240</Citation><ArticleIdList><ArticleId IdType="pubmed">27901465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2015 Sep 5;386(9997):995-1007</Citation><ArticleIdList><ArticleId IdType="pubmed">26049252</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Syst Transit. 2012;14(6):1-128</Citation><ArticleIdList><ArticleId IdType="pubmed">23149260</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2015 Sep;38:65-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26216766</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Rep. 2014;129 Suppl 4:35-41</Citation><ArticleIdList><ArticleId IdType="pubmed">25355973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2015 Oct 14;18(4):398-401</Citation><ArticleIdList><ArticleId IdType="pubmed">26468744</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000846 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000846 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:29976185
|texte= Preparedness and response against diseases with epidemic potential in the European Union: a qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:29976185" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |